Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06696339 · ClinicalTrials.gov registry record
Assessment of Heart Rate Measurement Accuracy for the PreemptiveAI SDK in Adults
A clinical trial of Heart Rate in the General Public, sponsored by PreemptiveAI.
- Active
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06696339: Active study of Heart Rate in the General Public, sponsored by PreemptiveAI.
NCT06696339 is a study of Heart Rate in the General Public that is active but no longer recruiting, run by PreemptiveAI. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06696339, a study of Heart Rate in the General Public, is active but no longer recruiting, sponsored by PreemptiveAI.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to assess the accuracy of the PreemptiveAI SDK to measure heart rate for adults as compared to an FDA-approved ground truth device. Participants will: * Complete a demographics and health history survey * Apply and wear ground truth equipment such as a pulse oximeter and ECG * Measure their heart rate 8 times with 4 different smartphones using the PreemptiveAI SDK
Primary Outcome
Root mean square error of heart rate compared to ground truth device
Conditions Studied
Interventions
- DEVICE PreemptiveAI SDK
Study Locations (1)
Washington
- Paul Allen Institute for Artificial Intelligence - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-10-03 |
| Est. Completion | 2025-03-01 |
What the registry record for NCT06696339 still lists
NCT06696339 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Heart Rate in the General Public appearing as the primary indexed condition, and to 1 intervention - of which PreemptiveAI SDK is the first listed.
NCT06696339 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06696339 about?
NCT06696339 is a clinical study titled "Assessment of Heart Rate Measurement Accuracy for the PreemptiveAI SDK in Adults". The goal of this clinical trial is to assess the accuracy of the PreemptiveAI SDK to measure heart rate for adults as compared to an FDA-approved ground truth device. Participants will: * Complete a demographics and health history survey * Apply and wear ground truth equipment such as a pulse oxim...
What is the current status of trial NCT06696339?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2024-10-03. Estimated completion is 2025-03-01.
What conditions does trial NCT06696339 study?
This clinical trial studies the following conditions: Heart Rate in the General Public.
What interventions are being tested in trial NCT06696339?
The interventions under investigation include: PreemptiveAI SDK (DEVICE).
Who is sponsoring clinical trial NCT06696339?
This trial is sponsored by PreemptiveAI, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06696339 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI